Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-121102
Filing Date
2025-12-12
Accepted
2025-12-12 14:10:11
Documents
5
Period of Report
2025-12-12

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0269497-6k_tiziana.htm 6-K 21870
2 TIZIANA LIFE SCIENCES LTD PRESS RELEASE, DATED DECEMBER 12, 2025 ea026949701ex99-1_tiziana.htm EX-99.1 26785
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4263
4 GRAPHIC ex99-1_002.jpg GRAPHIC 19434
5 GRAPHIC ex99-1_003.jpg GRAPHIC 57608
  Complete submission text file 0001213900-25-121102.txt   162232
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences Ltd (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 251567552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)